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physiological bone formation. It has previously been established that pharmacological doses of glucocorticoids facilitate arterial calcification. However, the consequences for vascular calcification of endogenous glucocorticoid elevation have yet to be established.
Glucocorticoids (cortisol, corticosterone) are released from the adrenal gland, but can also be generated within cells from 11-keto metabolites of glucocorticoids (cortisone, 11-dehydrocorticosterone ) by the enzyme, 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1). In the current study we hypothesised that endogenous glucocorticoids facilitate vascular smooth muscle cell (VSMC) calcification and investigated the receptor-mediated mechanism underpinning this process.
In vitro studies revealed increased phosphate-induced calcification in mouse VSMCs following treatment for 7 days with corticosterone (100 nM; 7.98 fold; P<0.01), 11-DHC (100 nM; 7.14 fold; P<0.05) and dexamethasone (10 nM; 7.16 fold; P<0.05), a synthetic glucocorticoid used as a positive control. Inhibition of 11β-HSD isoenzymes by 10 µM carbenoxolone reduced the calcification induced by 11-DHC (0.37 fold compared to treatment with 11-DHC alone; P<0.05). The glucocorticoid receptor (GR) antagonist mifepristone (10 µM) had no effect on VSMC calcification in response to corticosterone or 11-DHC. In contrast, the mineralocorticoid receptor (MR) antagonist eplerenone (10 µM) significantly decreased corticosterone-(0.81 fold compared to treatment with corticosterone alone; P<0.01) and 11-DHC-(0.64 fold compared to treatment with 11-DHC alone; P<0.01) driven VSMC calcification, suggesting this glucocorticoid effect is MR-driven and not GRdriven. Neither corticosterone nor 11-DHC altered the mRNA levels of the osteogenic markers PiT-1, Osx and Bmp2. However, DAPI staining of pyknotic nuclei and flow cytometry analysis of surface Annexin V expression showed that corticosterone induced apoptosis in VSMCs.
This study suggests that in mouse VSMCs, corticosterone acts through the MR to induce procalcification effects, and identifies 11β-HSD-inhibition as a novel potential treatment for vascular calcification.
Introduction
Vascular calcification is a marker of increased cardiovascular disease risk in ageing, including in diabetes, atherosclerosis and chronic kidney disease (CKD) ( Physiological glucocorticoids -primarily cortisol in humans and corticosterone in rats and mice -are steroid hormones produced by the adrenal cortex. Local glucocorticoid action on target tissues is determined by intracellular metabolism by the two isozymes of 11β-hydroxysteroid dehydrogenase (11β-HSD) which catalyze interconversion of active cortisol and corticosterone with inert cortisone and 11-dehydrocorticosterone (Hadoke et al., 2013) . 11β-HSD type 1, a predominant reductase in most intact cells, catalyzes the regeneration of active glucocorticoids, thus amplifying cellular action. 11β-HSD2 is a high-affinity dehydrogenase that inactivates glucocorticoids (Chapman et al., 2013) . Both isozymes of 11HSD are modestly expressed in the blood vessel wall, suggesting that they can influence vascular function by regulating local availability of active glucocorticoids (Hadoke et al., 2013 ).
In the absence of 11β-HSD2, endogenous glucocorticoids can bind to the mineralocorticoid receptor (MR) as well as the glucocorticoid receptor (GR) (Richardson et al., 2015) . Both MR and GR belong to the same nuclear hormone receptor superfamily, and share high sequence identity. MR has higher affinity for glucocorticoids than GR, and both receptors are It is therefore essential to establish the consequences for vascular calcification of endogenous glucocorticoid elevation and potential strategies for inhibition of calcification. The aims of this study were to undertake in vitro murine VSMC calcification studies to investigate both the identity of the receptor and the role of the 11β-HSD isoenzymes in corticosterone-induced calcification.
Materials and Methods

Mice
All animal experiments were performed under UK Home Office licensed approval in accordance with Directive 2010/63/EU of the European Parliament and were maintained in accordance with Home Office guidelines for the care and use of laboratory animals. C57BL/6 mice were supplied by Charles River Laboratories (Harlow, Essex, UK).
Preparation of VSMCs
Mice were euthanized by cervical dislocation. Primary murine VSMCs were isolated as described (Mackenzie et al., 2011) . Briefly, after removal of the adventitia, the aorta was opened to expose the endothelial layer under a dissection microscope. Tissues from eight animals were pooled and incubated with 1mg ml 
Determination of VSMC calcification
Analysis of gene expression
VSMCs were treated with corticosterone (Sigma) or 11-DHC (Steraloids, Newport, USA),
for 48 h in serum free α-MEM (Invitrogen). RNA was extracted using RNeasy total RNA (Qiagen Ltd, Crawley, West Sussex, UK), according to the manufacturer's instructions. RNA was quantified and reverse transcribed as previously described (Mackenzie et al., 2014) .
Levels of specific mRNAs were measured using the SYBR green detection method (Roche, East Sussex, UK) as previously reported . Primers were obtained from Qiagen (sequences not disclosed) for PiT-1 (NM_001159593), Bmp2 (NM_007553) and Msx2 (NM_013601).
Quantification of apoptosis
On reaching confluence, cells were serum starved for 24 h, then treated with 100 nM corticosterone for 48 h. Cells were harvested by trypsinization and re-suspended in 25 µl 1%
trypan blue (diluted 50% in PBS). Live cells, which exclude trypan blue and dead cells 
Statistical analysis
General Linear Model analysis and the Students t-test were used to assess the data. All data are expressed as the mean +/-S.E.M. Statistical analysis was performed using Minitab 16.
P<0.05 was considered to be significant.
Results
Glucocorticoids facilitates VSMC calcification
We initially examined the effects of physiological glucocorticoids on the calcification of VSMCs, with the synthetic glucocorticoid dexamethasone used as a positive control. Since arterial calcification is highly correlated with elevated serum Pi levels, VSMCs were cultured in growth medium containing high (3 mM) Pi as previously described (Zhu et al., Fig. 1B) . Surprisingly, 11-DHC was more potent than corticosterone, with a significant effect at 10 nM, compared to 100 nM for corticosterone.
A C C E P T E D M A N U S C R I P T
Using FBS stripped of steroids markedly increased the magnitude of the effects of both corticosterone and 11-DHC on VSMC calcification (7.98 fold, P<0.01 and 7.14 fold, P<0.05 respectively; Fig. 1C ). The 11β-HSD inhibitor carbenoxolone notably reduced 11-DHCinduced calcification of VSMCS (0.37 fold compared to treatment with 11-DHC alone, Fig. 1D ), confirming the 11β-HSD isoenzymes as key regulators of intracellular glucocorticoid levels (Chapman et al., 2013 ).
P<0.001,
Corticosterone and 11-DHC facilitate VSMC calcification through the MR.
In order to establish whether corticosterone acts via GR or MR to induce VSMC calcification, antagonists of both MR (eplerenone) and GR (mifepristone) were employed.
Mifepristone (10 µM) itself potentiated VSMC calcification, but did not alter the response to corticosterone ( Fig. 2A ) or 11-DHC (Fig. 2B) . However, eplerenone (10 µM) significantly attenuated the effect of corticosterone (0.81 fold compared to treatment with corticosterone alone; P<0.01) and 11-DHC-(0.64 fold compared to treatment with 11-DHC alone; P<0.01) on VSMC calcification.
Corticosterone and 11-DHC induce VSMC apoptosis.
Published data implicate the transdifferentiation of VSMCs to an osteoblast-like phenotype as a mechanism underlying the effects of dexamethasone upon vascular calcification (Mori et al., 1999 ). We therefore next tested whether the same is true for physiological glucocorticoids. Interestingly, neither corticosterone nor 11-DHC altered mRNA levels of key osteogenic markers: PiT-1 (Fig. 3A) , Osx (Fig. 3B) and Bmp2 (Fig. 3C) . Recent reports The present study also highlights that the effect of corticosterone and 11-DHC on driving VSMC calcification is more pronounced when charcoal stripped media is used to remove endogenous steroid ligands, suggesting an activating effect of endogenous MR ligands in normal, unstripped serum. These data support comparable findings demonstrating that aldosterone-induced CVC calcification via MR activation is also enhanced using charcoal stripped serum (Jaffe et al., 2007) .
Mechanistically, our data reveal that corticosterone reduces cell viability and stimulates 
